- Orthofix to Participate in Canaccord Genuity's 44th Annual Growth Conference
- Orthofix Names Stephanie Walsh Chief Human Resources Officer
- Orthofix to Report Second Quarter 2024 Financial Results
- Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System
- Michael Finegan Named Chair of the Orthofix Board of Directors
- Aviva McPherron Joins Orthofix as President of Global Operations and Quality
- Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer; Max Reinhardt Begins as President of Global Spine
- Orthofix Names Max Reinhardt President of Global Spine Business
- Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program
- Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail
More ▼
Key statistics
On Tuesday, Orthofix Medical Inc (OFIX:NSQ) closed at 16.29, -24.58% below its 52-week high of 21.60, set on Aug 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.96 |
---|---|
High | 16.52 |
Low | 15.88 |
Bid | 6.55 |
Offer | 22.00 |
Previous close | 16.29 |
Average volume | 324.28k |
---|---|
Shares outstanding | 37.53m |
Free float | 35.63m |
P/E (TTM) | -- |
Market cap | 611.35m USD |
EPS (TTM) | -3.40 USD |
Data delayed at least 15 minutes, as of Jul 23 2024 21:00 BST.
More ▼